33 research outputs found

    Flowchart of the study population.

    No full text
    <p>ALD, alcoholic liver disease; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease.</p

    Cumulative incidence rate of HCC according to the cause of cirrhosis.

    No full text
    <p>ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease.</p

    Characteristics of the study population at inclusion according to the cause of cirrhosis.

    No full text
    <p>Characteristics of the study population at inclusion according to the cause of cirrhosis.</p

    Additional file 1: of A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-Îą and ribavirin for chronic hepatitis C virus infection

    No full text
    Results (liver disease evolution) Description of data: Hepatic disease progression was assessed as a secondary objective in this study with optional data collection, and the limited data available are displayed in this additional file. (DOCX 17 kb
    corecore